Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara M. King
Observed names:
B KING,
B King,
B M King,
B. M. King,
Barbara King,
Barbara M King,
King, Barbara M.
show all 7
Institution:
South Australian Health and Medical Research Institute
Observed institutions:
South Australia Pathology,
Flinders University,
Women's and Children's Hospital,
Women's and Children's Health Network,
South Australian Health and Medical Research Institute
ORCID:
0000-0002-2715-1787
Observed ORCID:
0000-0002-2715-1787
OpenAlex ID:
A5101459549
Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.
1996
·
A C Crawley
, D A Brooks
, et al.
·
Journal of Clinical Investigation
·
139
PDF
Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA
2006
·
Allison C. Crawley
, Briony L. Gliddon
, et al.
·
Brain Research
·
109
Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice
2006
·
Kim M. Hemsley
, Barbara King
, et al.
·
Molecular Genetics and Metabolism
·
93
Effect of high dose, repeated intra‐cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice
2008
·
K. M. Hemsley
, H. Beard
, et al.
·
Genes Brain & Behavior
·
81
Examination of intravenous and intra‐CSF protein delivery for treatment of neurological disease
2009
·
Kim M. Hemsley
, Amanda J. Luck
, et al.
·
European Journal of Neuroscience
·
70
Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs—A proof of principle study
2009
·
Kim M. Hemsley
, Elizabeth J. Norman
, et al.
·
Molecular Genetics and Metabolism
·
67
Enzyme replacement reduces neuropathology in MPS IIIA dogs
2011
·
Allison C. Crawley
, Neil Marshall
, et al.
·
Neurobiology of Disease
·
57
Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models
1997
·
Doug A Brooks
, Barbara M King
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
47
PDF
Purification and Characterization of Recombinant Human Lysosomal α-Mannosidase
2001
·
Thomas Berg
, Barbara King
, et al.
·
Molecular Genetics and Metabolism
·
41
AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice and Achieves Widespread Distribution of SGSH in Large Animal Brains
2019
·
Michaël Hocquemiller
, Kim M. Hemsley
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
34
PDF
Neonatal Bone Marrow Transplantation in MPS IIIA Mice
2012
·
Adeline A Lau
, N. Jannah Shamsani
, et al.
·
JIMD Reports
·
33
Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA
2005
·
B KING
, P SAVAS
, et al.
·
Molecular Genetics and Metabolism
·
33
Caprine Mucopolysaccharidosis IIID: A Preliminary Trial of Enzyme Replacement Therapy
2000
·
Erinn Downs-Kelly
, Margaret Z. Jones
, et al.
·
Journal of Molecular Neuroscience
·
33
Delivery of therapeutic protein for prevention of neurodegenerative changes: Comparison of different CSF-delivery methods
2014
·
Neil R. Marshall
, Sofia Hassiotis
, et al.
·
Experimental Neurology
·
32
Enzyme replacement therapy in α-mannosidosis guinea-pigs
2006
·
A CRAWLEY
, B KING
, et al.
·
Molecular Genetics and Metabolism
·
30
Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice
2015
·
Helen Beard
, Amanda J. Luck
, et al.
·
Molecular Genetics and Metabolism
·
29
Treatment of canine fucosidosis by intracisternal enzyme infusion
2011
·
Gauthami S. Kondagari
, Barbara M. King
, et al.
·
Experimental Neurology
·
29
Disease stage determines the efficacy of treatment of a paediatric neurodegenerative disease
2014
·
Sofia Hassiotis
, Helen Beard
, et al.
·
European Journal of Neuroscience
·
24
Evaluation of enzyme dose and dose‐frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain
2014
·
Barbara King
, Neil Marshall
, et al.
·
Journal of Inherited Metabolic Disease
·
23
Synthetic Disaccharide Standards Enable Quantitative Analysis of Stored Heparan Sulfate in MPS IIIA Murine Brain Regions
2019
·
Qi Qi He
, Paul J. Trim
, et al.
·
ACS Chemical Neuroscience
·
21
A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome
2017
·
Adeline A. Lau
, Barbara M. King
, et al.
·
Journal of Inherited Metabolic Disease
·
20
Caprine Mucopolysaccharidosis IIID: Fetal and Neonatal Brain and Liver Glycosaminoglycan and Morphological Perturbations
2004
·
Margaret Z. Jones
, Joseph Alroy
, et al.
·
Journal of Molecular Neuroscience
·
19
Low‐dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA
2016
·
Barbara King
, Sofia Hassiotis
, et al.
·
Journal of Neurochemistry
·
18
Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric‐onset neurodegenerative disease, MPS IIIA
2016
·
Barbara King
, Neil R. Marshall
, et al.
·
Journal of Inherited Metabolic Disease
·
17
Immune response to enzyme replacement therapy: clinical signs of hypersensitivity reactions and altered enzyme distribution in a high titre rat model
1998
·
Doug A. Brooks
, John J. Hopwood
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
15
Show more works
View as search
Works count:
45
Citation count:
1,180
H-index:
20
I10-index:
28
Year
Topic
Type